In this tumor type, the inactivation of KEAP1 results in a constitutive activation of NRF2 and decrease in ROS, promoting tumor aggressiveness, metastasis and resistance to radiotherapy and oxidative stress (166). Here, KEAP1 is linked to neoplasm.